New study ties weight-loss drugs Wegovy, Ozempic to serious gastrointestinal conditions
CBC
Medicines in the same class as Novo Nordisk's popular weight-loss therapy Wegovy may carry an increased risk of pancreatitis, intestinal blockage and stomach paralysis compared to an older obesity drug, according to a study published on Thursday.
The study focused on two drugs from the class known as GLP-1 inhibitors, which help lower blood sugar levels for people with Type 2 diabetes: semaglutide is the active ingredient in Wegovy as well as Novo's diabetes drugs Ozempic and Rybelsus; liraglutide is the active ingredient in the company's earlier obesity medicine Saxenda and diabetes drug Victoza.
Nearly five in every 1,000 users of semaglutide drugs developed pancreatitis, compared to one of every 1,000 users of bupropion-naltrexone, the active ingredients in the weight-loss drug Contrave, according to a report in the JAMA medical journal. Contrave was approved in the U.S. in 2014 and in Canada in 2018.
For liraglutide, there were about eight cases of pancreatitis per 1,000 users.
Pancreatitis, or inflammation of the pancreas, can cause severe abdominal pain.
For stomach paralysis, researchers found roughly nine cases among every 1,000 users of semaglutide and about seven in liraglutide patients, compared with three among the same number of those taking bupropion-naltrexone.
WATCH | Health Canada assesses suicide risk of popular weight-loss drugs:
GLP-1 inhibitor medications mimic the actions of GLP-1, a natural hormone that helps control blood sugar levels in people with diabetes.
Mahyar Etminan, an epidemiologist at the University of British Columbia and senior author of the study, said up to two per cent of patients who used semaglutide and liraglutide medications to lose weight developed gastrointestinal problems.
"When you have millions of people taking them, that one per cent starts becoming a relatively big number," he said. "One of my main concerns is that they're long-term adverse events for which we really don't have much data, especially for those who are taking them just for weight loss and not for diabetes."
People with diabetes were not included in the study.
The study was observational, so it can only show associations, not whether the drugs caused the conditions.
The results of this study are consistent with effects observed in clinical trials in obese patients, said Penny Ward, an independent pharmaceutical physician and visiting professor in pharmaceutical medicine at King's College London in the U.K.
Ward told Science Media Centre that the study wasn't designed to assess all possible side-effects of the treatments.
The Canadian government has lost in court — again — to a First Nations grandmother fighting to fix extensive mould at her home on Oneida Nation of the Thames, near London, Ont.
Indigenous community members in British Columbia say they are celebrating after OneBC said it had removed MLA Dallas Brodie as its party leader.
Before NASA astronaut Sally Ride’s historic launch aboard the space shuttle in 1983 as the first American woman in space, she was asked a question: Would 100 tampons be the right number for her week-long mission?
Ashley Stevens has scars inside and out from her time in an Ontario jail.
Winnipeg resident John Ruhland first began taking medication for his depression in 2000 when a period of enormous stress — both at work and in his personal life — landed him in the hospital.
A group of young adults from Cumberland House Cree Nation travelled to British Columbia in November to take part in a program designed help them develop the skills needed to succeed should they decide to move away from their home northeast of Saskatoon.
In just a few short months, Canadian astronaut Jeremy Hansen will make history.
Chiefs from Treaty 8 First Nations of Alberta are calling for a pause on the pipeline memorandum of understanding until they are consulted and sign off on the potential project. And they're threatening legal action if that doesn't happen.
When dolphins swam onto the scene during a study on northern resident orcas off the coast of B.C., at least one researcher admitted to being a little annoyed.
Researchers say there's been a dramatic rise in the number of people going on medications to treat attention deficit/hyperactivity disorder in Ontario, suggesting factors such as more time spent online and the rise of private assessments for the mental condition could be behind the increase.
Baby, it’s cold outside — but it’s worth putting on that heavy winter coat, scarf and boots and heading out for one of the best meteor showers of the year: the Geminids.
Health officials are reminding Canadians to maintain healthy habits during the holiday season, as influenza leads to more school absences and hospitalizations.
For 40 years, staff at Nova Scotia's Annapolis Royal Historic Gardens thought their ginkgo tree was male.